Hypodermic Needle Destruction Unit to be Marketed by Remel Inc.

ATLANTA (July 26, 1999) - Biomedical Disposal, Inc. (Biomed) of Norcross announced today that they will partner with Remel Inc., for the immediate distribution of the Sharp_x^® Needle Destruction Unit (NDU) - a portable device designed to substantially reduce the possibility of accidental needlestick injuries by destroying a 19 to 27 gauge hypodermic needle at the point of use within two seconds. Biomed's long-term contract with Remel has an expected gross revenue in excess of $21.5 million for the first 18 months.

Remel Inc., headquartered in Lenexa, Kan., is a manufacturer and distributor of laboratory diagnostics. Biomed's contract with Remel will thrust the Sharp_x^® NDU's 21st century technology into both outpatient and in-patient treatment settings and clinical laboratories, providing a dramatic increase in the level of protection for health care professionals.

Founded in 1973, Remel Inc., has steadily earned a reputation as a leading full-service supplier for microbiology and diagnostic products over the past 25 years. In April of 1997, Remel became a subsidiary of Sybron International Corporation, and is currently a part of its Sybron Laboratories group of companies.

Biomed's Sharp_x^® NDU is an alternative to current needle destruction procedures in place in hospitals and medical offices worldwide. The Sharp_x^® device uses a rechargeable 7.2 volt NiCad battery to deliver an electrical current, vaporizing a ½ to 2 inch needle and capturing the debris in a replaceable aluminum-lined drawer. Needle debris is emptied by the operator into a sharps disposal container.

For further convenience, Sharp_x^® is constructed of lightweight, high-impact plastic and weighs only two pounds. Sharp_x^® attaches to a Sharp_x^® battery charger. The NiCad battery will destroy as many as 100 needles per charge and fully recharges within 45 to 90 minutes.

Approved by the U.S. Food and Drug Administration (FDA) in August of 1998, Sharp_x^® is currently in use throughout the United States. In December of 1998, Biomed began refining the manufacturing process for Sharp_x^® and to date has completed training of all personnel on the manufacturing line, completed two FDA Real Time Reviews and moved into full production.

In April of this year, Biomedical Disposal launched full production of the Sharp_x^® . Biomed's marketing of its Sharp_x^® product commenced in the state of California, where recent legislation has been signed, requiring that the state's Occupational Safety and Health Administration department (OSHA) use sharps prevention technology and environmentally sound products to protect their employees. Sharp_x^® is compliant with California's regulations and other states are pursuing similar legislation.

Biomedical Disposal Enlists Remel Laboratories for Distribution